文献速递神经技术与安全CT

从放射学视角识别接受华法林或直接口服抗凝药治疗的急性颅内出血患者:2359例急诊头颅CT的横断面观察研究

Acute ICH in patients identified as being treated with either warfarin or direct-acting oral anticoagulant agents (DOACs) from a radiology perspective; a cross-sectional observational of 2359 emergency CT head studies.
PubMed 文献 · Clin Radiol · 2019-12-24

本研究通过放射科信息系统回顾性检索2年内因抗凝治疗行急诊头颅CT的病例,最终纳入2359例(华法林1822例,DOAC 537例),比较急性颅内出血(ICH)阳性率。DOAC组ICH阳性率2.7%(需扫描数37)低于华法林组5.7%(需扫描数17.5),差异有统计学意义(P=0.0067);在有头部外伤史的患者中同样观察到类似趋势(2.14% vs 5.80%,P=0.02)。结论认为在急诊环境下,接受DOAC治疗的患者ICH发生率低于华法林,有外伤史者趋势相似。

要点

  • 急诊头颅CT中,DOAC组急性ICH阳性率为2.7%,低于华法林组的5.7%,差异有统计学意义(P=0.0067)。
  • 有头部外伤史的患者中,DOAC组ICH阳性率2.14%,仍低于华法林组的5.80%(P=0.02)。
  • 从放射科报告复核角度,接受抗凝治疗患者的急诊头颅CT需注意明确是否存在无争议的急性ICH。

核心结论

  • 在急诊环境下,接受DOAC治疗的患者急性ICH发生率低于接受华法林治疗者。
  • 在有头部外伤史的患者队列中,DOAC组同样表现出低于华法林组的ICH发生率趋势。

研究设计与样本

  • 回顾性横断面观察研究,通过医院放射科信息系统(RIS)自动检索2年期间临床信息提示使用华法林或DOAC的急诊头颅CT检查。
  • 最终纳入2359例,其中华法林组1822例,DOAC组537例;排除重复扫描和随访扫描。
  • 以每份扫描报告中是否存在无争议的急性ICH为判定依据,并复核外伤史和扫描时间等其他参数。

关键影像表现/征象

  • 119例头颅CT显示不同类型的急性ICH,其中华法林组104例,DOAC组15例。

诊断标准与关键数值

  • DOAC组急性ICH阳性率为2.7%(需扫描数37),华法林组为5.7%(需扫描数17.5),P=0.0067。
  • 有头部外伤史患者中,DOAC组急性ICH阳性率为2.14%(需扫描数46.7),华法林组为5.80%(需扫描数17.2),P=0.02。

临床应用与阅片要点

  • 在急诊头颅CT报告中,对接受抗凝治疗的患者应明确描述是否存在急性ICH,并注明抗凝药物类型(华法林或DOAC)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To determine and compare the rates of acute intracranial haemorrhage (ICH) in emergency computed tomography (CT) head studies performed on patients treated with either warfarin or a direct-acting oral anticoagulant agent (DOAC) in a real-world acute setting from a radiology service perspective.

METHOD: A retrospective automated search was undertaken via the hospital's radiology information system (RIS) for emergency CT head studies performed over a 2-year period where the clinical details indicated treatment with warfarin or a DOAC. The report of each scan was reviewed for the presence of unequivocal ICH. Duplicate and follow-up scans were excluded. Other parameters (trauma history and time of scan) were also reviewed.

RESULTS: Following exclusions, 2,359 cases were eligible for analysis; 1,822 patients were treated with warfarin and 537 treated with DOACs. One hundred and nineteen CT heads, of which 104 were treated with warfarin and 15 treated with DOACs, were positive for various types of ICH. The positive rate for ICH was lower in the DOACs group than the warfarin group; 2.7% (number needed to scan: 37) versus 5.7% (number needed to scan: 17.5; p=0.0067). This is also true in a cohort of patients who had traumatic head injury; 2.14% (number needed to scan: 46.7) versus 5.80% (number needed to scan: 17.2; p=0.02).

CONCLUSION: The present study has shown a lower rate of ICH in patients treated with DOACs compared to those treated with warfarin in an acute setting. A similar trend is demonstrated in a cohort of patients with a history of traumatic head injury.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Salimin L, Barber F, Limbada M, et al. Acute ICH in patients identified as being treated with either warfarin or direct-acting oral anticoagulant agents (DOACs) from a radiology perspective; a cross-sectional observational of 2359 emergency CT head studies. Clin Radiol. 2019. PMID: 31875831. doi:10.1016/j.crad.2019.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。